Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Innes

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
British Journal of Haematology|November 30, 2016
C-reactive protein prior to myeloablative allogeneic haematopoietic cell transplantation identifies patients at risk of early- and long-term mortalityAmit Patel, Richard M Szydlo, Holger W Auner, et al.
BMJ Open|February 5, 2026
Multiarm multistage randomised controlled trial of inflammatory signal inhibitors (MATIS) for patients hospitalised with COVID-19 pneumonia during the UK pandemicLorna Hazell, Clio Pillay, Victoria Cornelius, et al.
British Journal of Haematology|November 7, 2023
Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology GuidelineDonal P McLornan, Anna L Godfrey, Anna Green, et al.
British Journal of Haematology|December 1, 2023
The management of myelofibrosis: A British Society for Haematology GuidelineDonal P McLornan, Bethan Psaila, Joanne Ewing, et al.
British Journal of Haematology|November 11, 2021
Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapyStephen Booth, Helen M Curley, Csilla Varnai, et al.
British Journal of Haematology|May 3, 2026
Real-world treatment patterns and outcomes in accelerated and blast-phase myeloproliferative neoplasms: Insights from a large multi-centre cohort analysis in the United KingdomAlexandros Rampotas, Gabriel Naylor-Layland, Clare Brown, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
British Journal of Haematology|November 30, 2016
C-reactive protein prior to myeloablative allogeneic haematopoietic cell transplantation identifies patients at risk of early- and long-term mortalityAmit Patel, Richard M Szydlo, Holger W Auner, et al.
BMJ Open|February 5, 2026
Multiarm multistage randomised controlled trial of inflammatory signal inhibitors (MATIS) for patients hospitalised with COVID-19 pneumonia during the UK pandemicLorna Hazell, Clio Pillay, Victoria Cornelius, et al.
British Journal of Haematology|November 7, 2023
Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology GuidelineDonal P McLornan, Anna L Godfrey, Anna Green, et al.
British Journal of Haematology|December 1, 2023
The management of myelofibrosis: A British Society for Haematology GuidelineDonal P McLornan, Bethan Psaila, Joanne Ewing, et al.
British Journal of Haematology|November 11, 2021
Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapyStephen Booth, Helen M Curley, Csilla Varnai, et al.
British Journal of Haematology|May 3, 2026
Real-world treatment patterns and outcomes in accelerated and blast-phase myeloproliferative neoplasms: Insights from a large multi-centre cohort analysis in the United KingdomAlexandros Rampotas, Gabriel Naylor-Layland, Clare Brown, et al.
Pageof 3